Sorry, Sold Out

Nightingale (NN – 1) Feminised Seeds

$15.82$80.50

Please select pack size below

We send seeds in discreet stealth packaging worldwide.

We're Social - Spread the Love

Nightingale (NN – 1) Feminised Cannabis Seeds by Medical Marijuana Genetics

Named after Florence Nightingale the founder of modern nursing, is a poly hybrid indica bred from the legendary Shiskaberry and CD-1.

During testing, its CBD levels have ranged from 20.3% to 10.3%.  The THC level varied the most out of all of the strains sold by Medical Marijuana Genetics, meaning this strain varied from between a 1:1 strain to a 20:1 strain.  If you need fairly precise THC levels and do not have access to testing then beware of this strain.  If you are looking for a high CBD, low THC strain and have access to a laboratory then this is one to test.

It is worth noting that from our research – and unlike its Candida parent – it appears that the indica phenotype that this plant produces is the 20:1 pheno, with the more sativa pheno producing a 1:1 strain.

Nightingale’s berry lineage is evident in many of its characteristics, with striking purple leaves in flower, sweet berry aroma and high yield. It is perfect for night time use and can be utilised for those suffering with insomnia and anxiety, as well as a host of other medical conditions. Nightingale (NN-1) is suitable for all growing environments and is suitable for making extractions and vaping/smoking.

Buy Medical Marijuana Genetics Nightingale (NN – 1) Feminised Marijuana Seeds online today. Here at Coffee Shop Seeds we offer the best, cheapest cannabis seeds online from the worlds best cannabis seed banks.

Characteristics

    • No. of Seeds: No selection

      1, 3, 5, 10

      THC Content: No selection

      0.68%-9%

      CBD Content: No selection

      High (5% +)

      Genetics: No selection

      Oldberry x CD-1

      Breeder: No selection

      Effect: No selection

      ,

      Flowering Time: No selection

      8-9 weeks

      Flowering Type: No selection

      Photoperiod

      Grows: No selection

      Greenhouse, Grows Indoors, Grows outdoors

      Medical Conditions: No selection

      , , , , , , ,

      Medical Properties: No selection

      Chronic Pain, Muscle Spasms, Nausea, Vomiting, Fibromyalgia, Multiple Sclerosis, Lupus, Insomnia

      Sex: No selection

      Feminised

      Variety: No selection

      Mostly Indica

      Yield: No selection

      Medium, High

No. of Seeds: No selection

1, 3, 5, 10

THC Content: No selection

0.68%-9%

CBD Content: No selection

High (5% +)

Genetics: No selection

Oldberry x CD-1

Breeder: No selection

Effect: No selection

,

Flowering Time: No selection

8-9 weeks

Flowering Type: No selection

Photoperiod

Grows: No selection

Greenhouse, Grows Indoors, Grows outdoors

Medical Conditions: No selection

, , , , , , ,

Medical Properties: No selection

Chronic Pain, Muscle Spasms, Nausea, Vomiting, Fibromyalgia, Multiple Sclerosis, Lupus, Insomnia

Sex: No selection

Feminised

Variety: No selection

Mostly Indica

Yield: No selection

Medium, High

Brand

Medical Marijuana Genetics

Medical Marijuana Genetics first learnt of the therapeutic properties of the cannabis plant in 2014. Whilst desperately treating the symptoms of one of the founders mother’s late stage pancreatic cancer. Not long after her first dose of cannabis oil, she was able to move around relatively pain free. This enabled her to tend to her beloved garden, in the weeks leading up to her death.Medical Marijuana Genetics teamed with award winning breeders from Spain, with the initial aim of creating a line of CBD dominant cannabis strains. Using genetics from a number of well established strains, Medical Marijuana Genetics successfully created Candida (CD-1). Aptly named after the founder’s mother and meaning ‘bright light’ in Latin.Medical Marijuana Genetics have had results ranging from 20.65% CBD with 0.7% THC to 10.65% CBD to 0.39% THC. These percentages represent the highest known consistent ratios in a CBD-rich seed strain ever created in Europe.Medical Marijuana Genetics created a further 12 elite strains using Candida as a parent. They have selected their favourite's of these to release alongside their flagship Candida strain. These have been selected to provide access (within lawful jurisdiction) to the widest range of therapeutics that the cannabis plant, and CBD in particular, has to offer. This includes treatments for symptoms such chronic pain, inflammation, seizures, convulsions, gastro-intestinal disorders, nausea, vomiting, skin conditions, bacterial infections, anxiety, depression, cancer cell growth and much more. All of the strains that are being launched are CBD dominant and have a CBD content of over 8%, but some strains veer towards a 1:1 ratio.In 2017 MMG strains won 5 Spannabis Champions Cups in Barcelona and Madrid. The awards include a 1st (BCN), 2nd and 3rd place (MAD)  in CBD categories for Orinoco OR1, Candida CD1 and Nightingale NN1 and a 2nd and 3rd in the Indica category for as yet unreleased genetics.
Medical marijuana Genetics Cannabis Seed breeders
Leave your review
Rating

Notify me when the item is back in stock.